Multicentric standardization of minimal/measurable residual disease in B-cell precursor acute lymphoblastic leukaemia using next-generation flow cytometry in a low/middle-level income country

Br J Haematol. 2023 Feb;200(3):381-384. doi: 10.1111/bjh.18499. Epub 2022 Oct 12.
No abstract available

Keywords: B cell acute lymphoblastic leukaemia; B-ALL; MRD; flow cytometry; minimal residual disease; next generation flow.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Burkitt Lymphoma*
  • Flow Cytometry
  • Humans
  • Neoplasm, Residual
  • Precursor B-Cell Lymphoblastic Leukemia-Lymphoma* / diagnosis
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma*